Zurich Cantonal Bank’s Cidara Therapeutics CDTX Stock Holding History

Zurich Cantonal Bank’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,671	Closed	-$811K	–	2741
2025 Q4	$811K	Buy	+3,671	New	+$593K	﹤0.01%	1469
2017 Q2	–	Sell	-475	Closed	-$74K	–	2533
2017 Q1	$74K	Buy	+475	New	+$83.4K	﹤0.01%	1544

Zurich Cantonal Bank's CDTX Position: Q1 2026 in Review

Zurich Cantonal Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,671 shares — an estimated $811K sold.

Zurich Cantonal Bank first reported a position in CDTX in Q1 2017 and held it in 2 quarters. The position peaked at $811K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Zurich Cantonal Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Zurich Cantonal Bank sold 3,671 Cidara Therapeutics shares in Q1 2026, an estimated $811K.
Zurich Cantonal Bank first reported a position in Cidara Therapeutics in Q1 2017 and held it in 2 quarters.
Zurich Cantonal Bank's Cidara Therapeutics position peaked at $811K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.